Anaplastic large cell lymphoma (ALCL), ALK-negative, is a subtype of non-Hodgkin lymphoma characterized by the presence of large, atypical lymphoid cells. This variant typically presents with lymphadenopathy, particularly in intra-abdominal nodes, and is associated with aggressive clinical behavior. Accurate coding with ICD-10 Code C84.73 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring appropriate treatment and resource allocation.
ICD-10 Code C84.73 specifically denotes Anaplastic large cell lymphoma, ALK-negative, affecting intra-abdominal lymph nodes. This code is utilized when documenting cases of ALCL that do not express the anaplastic lymphoma kinase (ALK) protein, which is critical for distinguishing this subtype from ALK-positive variants. It should be used in clinical documentation and billing when diagnosing patients with this specific lymphoma type.
Anaplastic large cell lymphoma, ALK-negative, is a hematological malignancy that arises from T-cells and is characterized by the proliferation of large, atypical lymphoid cells. The condition often presents with systemic symptoms and requires prompt medical intervention due to its aggressive nature.
ICD-10 Code C84.73 is integral in SOAP notes for documenting the clinical presentation, assessment, and treatment of patients with Anaplastic large cell lymphoma, ALK-negative. It aids in capturing the severity and specifics of the condition in both acute and chronic care settings.
In SOAP notes, ICD-10 Code C84.73 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Anaplastic large cell lymphoma, ALK-negative. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
The management of Anaplastic large cell lymphoma, ALK-negative, often necessitates hospitalization due to its aggressive nature. Treatment typically involves chemotherapy and may include targeted therapies.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C84.73 is crucial for billing purposes in hospital, ER, or infectious disease care settings, ensuring accurate reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 85025 | Complete blood count (CBC) with automated differential white blood cell count. |
| 77021 | Computed tomography, abdomen, with contrast. |
Common Questions About Using ICD-10 Code C84.73 for Anaplastic large cell lymphoma, ALK-neg, intra-abd nodes
What are the common symptoms of Anaplastic large cell lymphoma?
Common symptoms include swollen lymph nodes, abdominal pain, fever, night sweats, and unexplained weight loss. Patients may also experience fatigue and general malaise.
How is Anaplastic large cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies, and biopsy of affected lymph nodes to confirm the presence of atypical lymphoid cells.
What treatment options are available for Anaplastic large cell lymphoma?
Treatment usually involves chemotherapy, and in some cases, targeted therapies may be considered. Supportive care is also important to manage symptoms and side effects.
How does ICD-10 Code C84.73 impact billing?
ICD-10 Code C84.73 is essential for accurate billing as it specifies the diagnosis, ensuring that healthcare providers receive appropriate reimbursement for the services rendered.
Clinical Notes
SOAP notes
DAP notes
AI medical notes